Ayurcann Holdings Corp.
Ayurcann Holdings Corp.
Your view on AYURF
Overview
What the company does, where it operates, and who runs it.
About Ayurcann Holdings Corp.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Igal Sudman
- Headquarters
- 1080 Brock Road, Pickering, ON, CA
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Igal Sudman
- Headquarters
- 1080 Brock Road, Pickering, ON, CA
Ayurcann Holdings Corp. provides post-harvest outsourcing solutions to licensed cannabis producers in Canada.
The company offers end-to-end outsourcing solutions, including extraction and refinement, bulk distillate oil sales, formulation and white label manufacturing, and fulfillment and distribution, as well as customized packaging solutions and inventory management services. It also provides medicinal cannabis, such as tincture, vapes, and topicals.
In addition, the company operates Ayurcann marketplace, an online cannabis market for medical cannabis consumers. The company was founded in 2018 and is headquartered in Pickering, Canada.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Ayurcann Holdings Corp., and the rating behind it. AYURF last traded at $0.0020; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Ayurcann Holdings Corp.. Starting points for Ayurcann Holdings Corp.: EPS -$0.02, beta 1.77 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Ayurcann Holdings Corp.. Ayurcann Holdings Corp. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Ayurcann Holdings Corp.. Trailing twelve-month EPS for Ayurcann Holdings Corp. stands at -$0.02. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Ayurcann Holdings Corp.. Ayurcann Holdings Corp. has reported as a listed company since 2014. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Ayurcann Holdings Corp. valued side by side against its closest peers. Ayurcann Holdings Corp. is measured against Drug Manufacturers - Specialty & Generic peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Ayurcann Holdings Corp., and how their positions are changing. At a $389,408 market value, institutional positions materially move Ayurcann Holdings Corp.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Ayurcann Holdings Corp. executives and directors. Shares of Ayurcann Holdings Corp. have traded between $0.0020 and $0.03 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Ayurcann Holdings Corp.. Ayurcann Holdings Corp. is a $389,408 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Ayurcann Holdings Corp.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Ayurcann Holdings Corp.. Coverage tracks Ayurcann Holdings Corp. within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.